FAZYX
Price
$13.84
Change
+$0.06 (+0.44%)
Updated
May 8 closing price
Net Assets
2.74B
RLBEX
Price
$34.31
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
Ad is loading...

FAZYX vs RLBEX

Header iconFAZYX vs RLBEX Comparison
Open Charts FAZYX vs RLBEXBanner chart's image
Fidelity Advisor Multi-Asset Income M
Price$13.84
Change+$0.06 (+0.44%)
VolumeN/A
Net Assets2.74B
American Funds American Balanced R4
Price$34.31
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
FAZYX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAZYX vs. RLBEX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAZYX is a Buy and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 234B vs. FAZYX (2.74B). FAZYX pays higher dividends than RLBEX: FAZYX (3.68) vs RLBEX (1.98). FAZYX was incepted earlier than RLBEX: FAZYX (10 years) vs RLBEX (23 years). FAZYX (1.08) is less costly to investors than RLBEX (0.59). FAZYX is a more actively managed with annual turnover of: 230.00 vs. RLBEX (44.00). FAZYX has a lower initial minimum investment than RLBEX: FAZYX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 4.73 vs. FAZYX (4.10). FAZYX return over 5 years is better than : 49.04 vs. RLBEX (36.69).
FAZYXRLBEXFAZYX / RLBEX
Total Expense Ratio1.080.59183%
Annual Report Gross Expense Ratio1.080.59183%
Fund Existence10 years23 years-
Gain YTD-1.3810.425-325%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.74B234B1%
Annual Yield % from dividends3.681.98186%
Returns for 1 year4.104.7387%
Returns for 3 years19.3021.8488%
Returns for 5 years49.0436.69134%
Returns for 10 yearsN/A52.56-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMGYX29.76N/A
N/A
Lord Abbett Growth Opportunities I
SMVFX10.67N/A
N/A
Virtus Ceredex Mid-Cap Value Equity C
OANBX35.46N/A
N/A
Oakmark Equity and Income Institutional
RYECX167.62N/A
N/A
Rydex Energy C
BHCFX17.64N/A
N/A
Baron Health Care Retail